Choroidal Neovascularization in Best Vitellif...

Dr. Edmund Tsui and author Dr. Douglas A. Jabs discuss the results of the ADVISE Trial, designed to compare adalimumab to conventional immunosuppressive drugs for the treatment of non-infectious intermediate, posterior, and panuveitides. From Dr. Jab's Ophthalmology article, "Ada ...  Show more

Our newest host and Social Media Editor, Dr. Rukhsana Mirza, interviews Dr. Phoebe Lin. Together, they discuss Dr. Lin's study on whether an intestinal microbial signature is associated with advanced age-related macular degeneration and the relationship between the microbiota and ...  Show more

Drs. Jason Comander and Rachel Huckfeldt join host Dr. Ben Young to review management considerations for patients with retinitis pigmentosa (RP). The discussion highlights the winding story of nutritional supplementation recommendations for vitamin A, and the importance of reanal ...  Show more

Dr. Thomas Johnson sits down with host Dr. Andrew Pouw to share exciting developments in regenerative stem cell research that may one day cure glaucoma. Learn more about Dr. Johnson's work in a recent presentation he delivered on behalf of the Glaucoma Foundation, and through the ...  Show more

In today's episode, host Dr. Jay Sridhar is joined by Dr. Bobeck Modjtahedi to discuss the American Academy of Ophthalmology's new guidelines on autoimmune retinopathy ...

<div>Optometrists commonly encounter corneal conditions in practice—such as keratoconus, Fuch’s endothelial corneal dystrophy and recurrent corneal epithelial erosion syndrome. As Professor Sai Kolli explains in this podcast, the management of corneal dystrophies may involve moni ...  Show more